Publications

Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study.

Goldacre R. et al, (2024), J Neurol Neurosurg Psychiatry

Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003–2023

Goldacre R., (2024), Multiple Sclerosis Journal

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health, 8, 190 - 200

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914

Hospital admissions for group A streptococcal infections in England: current rates and historical perspective.

Iro MA. et al, (2023), Lancet Infect Dis, 23, e326 - e327

Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries.

Wright FL. et al, (2023), Eur Heart J Qual Care Clin Outcomes, 9, 377 - 388

External rectal prolapse: more than meets the eye

Yiasemidou M. et al, (2023), Techniques in Coloproctology

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk None. and RECOVERY Collaborative Group None., (2023), Lancet, 401, 1499 - 1507

A national cohort study using routine data to investigate the association between ethnicity and the provision of care in obstetric anaesthesia in England between 2011 and 2021

Bamber JH. et al, (2023), Anaesthesia

Central nervous system abscesses and empyemas in England: epidemiological trends over five decades

Iro MA. et al, (2023), Journal of Infection

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records.

Thygesen JH. et al, (2022), Lancet Digit Health, 4, e542 - e557

Balancing quality and equity of access in specialist neonatal surgery: implications of the GIRFT report

Lansdale N. et al, (2022), British Journal of Surgery

Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries.

Camacho X. et al, (2022), Lancet Public Health, 7, e229 - e239

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676

Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study.

Kadambari S. et al, (2022), BMJ, 376

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151

Esophageal achalasia diagnosed in people previously diagnosed with an eating disorder: Epidemiological study using record-linkage.

Goldacre M. et al, (2021), Int J Eat Disord, 54, 2015 - 2018

Group B Streptococcal Disease in England (1998 - 2017): A Population-based Observational Study.

Kadambari S. et al, (2021), Clin Infect Dis, 72, e791 - e798

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2021), Lancet, 397, 2049 - 2059

Cookies on this website

Publications